Search

everythinglearnresearchcommunity

for

Search:↓

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

People with pattern hair loss have higher polyamine levels in the top of their head compared to the back.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Specialized ribosomes affect aging in human skin cells.

The document lists various dermatology topics, treatments, and diagnostic methods.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

Videodermoscopy improves diagnosis of hair and scalp disorders and may reduce scalp biopsies.

Isotretinoin is highly effective in treating severe acne, rosacea, and gram-negative folliculitis.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Generalized pustular psoriasis patients often need strong medication and careful treatment due to flare-ups and complications.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

High-frequency ultrasonography is a useful but underused tool in dermatology for assessing skin cancers, monitoring diseases, and evaluating treatments.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

Some medications can cause acne, and stopping these drugs is the main treatment.

HIV can cause various nail and hair disorders, important for early diagnosis and treatment.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Thyroid hormones are important for skin health and might help treat skin diseases, but more research is needed to understand their effects fully.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

Thyroid hormone may speed up wound healing and hair growth, but more research is needed to understand its role in skin repair and use as a treatment.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Many patients on new leukemia drugs had mild to moderate skin reactions.